MED logo

Medifast, Inc. (MED)

Profile

Full Name

Medifast, Inc.

Ticker

NYSE: MED

Exchange

NYSE

Sector

Consumer Cyclical

Industry

Personal Services

Country

United States

IPO

December 30, 1993

Indexes

Not included

Website

http://medifastinc.com

Employees

504

Key Details

Price

$14.40(-1.91%)

Market cap

$158.27M(Small cap)

Last Dividend

$1.65

TTM Dividend yield

-

Annual revenue

$602.46M(-43.80% YoY)

Annual EPS

$0.19(-97.91% YoY)

PE ratio

-

Next earnings date

Aug 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $14.40
    MED price is $14.40

    30-Day Relative Volume

    0.60
    MED 30-day relative volume is 0.60

    Price Performance

    Price Most recent change

    -1.91%
    MED price was down -1.91% on Jul 11, 2025

    Price YTD change

    -18.27%
    MED price is down -18.27% since January 1st

    Price 1-year change

    -24.96%
    MED price is down -24.96% year-on-year

    Price 3-year change

    -91.87%
    MED price is down -91.87% over the past 3 years

    Price Range

    Price All-time high

    $336.99
    MED price is currently -95.73% below its historical high of $336.99

    Price 3-year low

    $11.57
    MED price is currently +24.46% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $158.27M
    MED market capitalization is $158.27 million

    Market cap 3-year change

    -91.89%
    MED market capitalization is down -91.89% over the past 3 years

    Market cap All-time high

    $3.91B
    MED market capitalization is currently -95.95% below its historical high of $3.91 billion

    Market cap sector rank

    31.98%
    MED market capitalization is higher than 31.98% of companies in Consumer Cyclical sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.49%
    MED shares outstanding is up +0.49% year-on-year

    Shares Outstanding 3-Year Change

    -0.25%
    MED shares outstanding is down -0.25% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.41
    MED beta is 0.41

    200-day SMA

    $15.68
    MED price is currently -8.14% below its 200-day simple moving average

    50-day SMA

    $13.60
    MED price is currently +5.91% above its 50-day simple moving average

    RSI

    54.29
    MED 14-day relative strength index is 54.29

    Volume

    0.60
    MED 30-day relative volume is 0.60

    ATR

    $0.51
    MED average true range is $0.51

    10-day Historical Volatility

    40.06%
    MED 10-day historical volatility is 40.06%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $1.65
    MED last dividend was $1.65 per share, with an ex-dividend date of September 18, 2023

    Next Dividend

    -
    MED next dividend has not yet been announced

    Dividend per share

    Dividend per share

    -
    MED annual dividend per share value is unknown

    Dividend per share Sector Rank

    -
    MED annual dividend per share is unknown

    Dividend per share 1-Year Change

    -
    MED annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    MED annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    -
    MED annual dividend yield value is unknown

    Dividend yield Sector Rank

    -
    MED annual dividend yield is unknown

    Other

    Payout ratio

    34.19%
    MED annual payout ratio is 34.19%

    Dividends paid

    $715.00K
    MED annual dividends paid is $715.00 thousand

    Free cash flow

    $17.02M
    MED annual free cash flow is $17.02 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $602.46M
    MED annual revenue is $602.46 million

    Revenue Analysts estimate

    $390.10M
    MED annual revenue is currently +54.44% higher than the consensus analysts' forecast

    Revenue 1-year change

    -43.8%
    MED annual revenue is down -43.8% year-on-year

    Revenue Sector rank

    40.88%
    MED annual revenue is higher than 40.88% of companies in Consumer Cyclical sector

    EPS

    EPS

    $0.19
    MED annual earnings per share is $0.19

    EPS Analysts estimate

    -$1.00
    MED annual earnings per share is currently -119.00% lower than the consensus analysts' forecast

    EPS 1-year change

    -97.91%
    MED annual earnings per share is down -97.91% year-on-year

    EPS Sector rank

    49.83%
    MED annual earnings per share is higher than 49.83% of companies in Consumer Cyclical sector

    Profit

    Gross profit

    $444.62M
    MED annual gross profit is $444.62 million

    Gross margin

    73.80%
    MED annual gross profit margin is 73.80%

    Operating profit

    $2.88M
    MED annual operating income is $2.88 million

    Operating margin

    0.48%
    MED annual operating profit margin is 0.48%

    Net income

    $2.09M
    MED annual net profit is $2.09 million

    Net margin

    0.35%
    MED annual net profit margin is 0.35%

    Expenses

    Total expenses

    $599.59M
    MED annual total expenses is $599.59 million

    Operating expenses

    $441.75M
    MED annual total operating expenses is $441.75 million

    Cost of goods sold

    $157.84M
    MED annual cost of goods sold is $157.84 million

    Selling, general & administrative expenses

    $441.75M
    MED annual SGA is $441.75 million

    Depreciation and amortization

    $12.71M
    MED annual depreciation & amortization is $12.71 million

    Interest expense

    -
    MED annual interest expense value is unknown

    Income tax

    $1.70M
    MED annual income tax is $1.70 million

    EBIT & EBITDA

    EBIT

    $2.88M
    MED annual earnings before interest & taxes is $2.88 million

    EBITDA

    $15.59M
    MED annual EBITDA is $15.59 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $284.21M
    MED annual total assets is $284.21 million

    Non current assets

    $69.81M
    MED annual long term assets is $69.81 million

    Current assets

    $214.40M
    MED annual total current assets is $214.40 million

    Cash and cash equivalents

    $90.93M
    MED annual cash & cash equivalents is $90.93 million

    Accounts receivable

    -
    MED annual accounts receivable value is unknown

    Inventory

    $42.42M
    MED annual inventory is $42.42 million

    Liabilities

    Total liabilities

    $74.10M
    MED annual total liabilities is $74.10 million

    Long term liabilities

    $9.94M
    MED annual total long term liabilities is $9.94 million

    Current liabilities

    $64.16M
    MED annual total current liabilities is $64.16 million

    Accounts payable

    $23.05M
    MED annual accounts payable is $23.05 million

    Debt

    Total debt

    $16.13M
    MED annual total debt is $16.13 million

    Total debt 1-year change

    -26.74%
    MED annual total debt is down -26.74% year-on-year

    Long term debt

    $9.94M
    MED annual long term debt is $9.94 million

    Short term debt

    $6.18M
    MED annual short term debt is $6.18 million

    Equity & Capital

    Shareholders equity

    $210.11M
    MED annual stockholders equity is $210.11 million

    Book value

    $210.11M
    MED annual book value is $210.11 million

    Retained earnings

    $176.78M
    MED annual retained earnings is $176.78 million

    Working capital

    $150.24M
    MED annual working capital is $150.24 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $24.48M
    MED annual cash flow from operations is $24.48 million

    Cash from operations 1-year change

    -83.42%
    MED annual cash flow from operations is down -83.42% year-on-year

    Cash from investing

    -$26.52M
    MED annual cash flow from investing activities is -$26.52 million

    Cash from investing 1-year change

    +56.56%
    MED annual cash flow from investing activities is up +56.56% year-on-year

    Cash from financing

    -$1.51M
    MED annual cash flow from financing activities is -$1.51 million

    Cash from financing 1-year change

    +98.1%
    MED annual cash flow from financing activities is up +98.1% year-on-year

    CAPEX

    CAPEX

    $7.45M
    MED annual capital expenditures is $7.45 million

    CAPEX 1-year change

    +14.98%
    MED annual capital expenditures is up +14.98% year-on-year

    Free Cash Flow

    Free cash flow

    $17.02M
    MED annual free cash flow is $17.02 million

    Free cash flow 1-year change

    -87.94%
    MED annual free cash flow is down -87.94% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    73.80%
    MED annual gross profit margin is 73.80%

    Operating margin

    0.48%
    MED annual operating profit margin is 0.48%

    Net margin

    0.35%
    MED annual net profit margin is 0.35%

    ROA & ROE

    ROA

    0.70%
    MED annual return on assets is 0.70%

    ROE

    1.02%
    MED annual return on equity is 1.02%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    MED price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    MED price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.75
    MED price to book ratio is 0.75

    PB ratio Sector rank

    31.69%
    MED price to book ratio is higher than 31.69% of companies in Consumer Cyclical sector

    PS Ratio

    PS ratio

    0.29
    MED price to sales ratio is 0.29

    PS ratio Sector rank

    21.02%
    MED price to sales ratio is higher than 21.02% of companies in Consumer Cyclical sector

    Enterprise value

    Enterprise value

    $81.16M
    MED enterprise value is $81.16 million

    Enterprise value Sector rank

    19.28%
    MED enterprise value is higher than 19.28% of companies in Consumer Cyclical sector

    EV/EBITDA

    EV/EBITDA

    12.68
    MED EV/EBITDA is 12.68

    EV/EBITDA Sector rank

    67.55%
    MED EV/EBITDA is higher than 67.55% of companies in Consumer Cyclical sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.34
    MED annual current ratio is 3.34

    Quick ratio

    2.68
    MED annual quick ratio is 2.68

    Leverage

    Debt to equity

    0.00
    MED annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    MED annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    4
    MED piotroski f-score is 4

    Altman Z-Score

    4.94
    MED altman z-score is 4.94

    Analyst ratings

    Recent major analysts updates

    Feb 19, 25 DA Davidson
    Neutral
    Nov 5, 24 DA Davidson
    Neutral
    Jul 22, 24 DA Davidson
    Underperform
    Jun 5, 24 DA Davidson
    Underperform
    Apr 30, 24 DA Davidson
    Neutral
    Feb 21, 24 DA Davidson
    Neutral
    Oct 13, 23 Stephens & Co.
    Equal-Weight
    Aug 8, 23 DA Davidson
    Neutral
    Jul 31, 23 DA Davidson
    Neutral
    May 2, 23 DA Davidson
    Neutral

    Institutional Ownership

    Screeners with MED included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Stocks recommended to hold
    Best performing stocks last 3 months
    Stocks below analysts price target
    All stocks
    High Altman Z score stocks
    Consumer cyclical sector
    Ex Dividend dates calendar
    • What is the ticker symbol for Medifast, Inc.?
    • Does Medifast, Inc. pay dividends?
    • What sector is Medifast, Inc. in?
    • What industry is Medifast, Inc. in?
    • What country is Medifast, Inc. based in?
    • When did Medifast, Inc. go public?
    • Is Medifast, Inc. in the S&P 500?
    • Is Medifast, Inc. in the NASDAQ 100?
    • Is Medifast, Inc. in the Dow Jones?
    • When was Medifast, Inc.'s last earnings report?
    • When does Medifast, Inc. report earnings?

    What is the ticker symbol for Medifast, Inc.?

    The ticker symbol for Medifast, Inc. is NYSE:MED

    Does Medifast, Inc. pay dividends?

    No, Medifast, Inc. does not pay dividends

    What sector is Medifast, Inc. in?

    Medifast, Inc. is in the Consumer Cyclical sector

    What industry is Medifast, Inc. in?

    Medifast, Inc. is in the Personal Services industry

    What country is Medifast, Inc. based in?

    Medifast, Inc. is headquartered in United States

    When did Medifast, Inc. go public?

    Medifast, Inc.'s initial public offering (IPO) was on December 30, 1993

    Is Medifast, Inc. in the S&P 500?

    No, Medifast, Inc. is not included in the S&P 500 index

    Is Medifast, Inc. in the NASDAQ 100?

    No, Medifast, Inc. is not included in the NASDAQ 100 index

    Is Medifast, Inc. in the Dow Jones?

    No, Medifast, Inc. is not included in the Dow Jones index

    When was Medifast, Inc.'s last earnings report?

    Medifast, Inc.'s most recent earnings report was on April 28, 2025

    When does Medifast, Inc. report earnings?

    The next expected earnings date for Medifast, Inc. is August 5, 2025
    On this page